Skip to main content
Tobacco Control logoLink to Tobacco Control
. 2003 Dec;12(Suppl 3):iii38–iii44. doi: 10.1136/tc.12.suppl_3.iii38

"A deep fragrance of academia": the Australian Tobacco Research Foundation

S Chapman, S Carter, M Peters
PMCID: PMC1766117  PMID: 14645947

Abstract

Objectives: (1) To review the history of the tobacco industry supported Australian Tobacco Research Foundation (ATRF)(1970–1994) for evidence of the industry's use of the Foundation to further its objectives that "more research was needed" on smoking and health and to promulgate the view that nicotine was not addictive. (2) To review efforts by public health advocates to discredit the ATRF as a public relations tool used by the Australian industry.

Methods: Systematic search of previously internal industry documents released through the US Master Settlement Agreement.

Results: The ATRF was headed by prestigious Australian medical scientists, with at least one considered by the industry to be "industry positive". An international ATRF symposium on nicotine was vetted by the industry and heavily attended by industry approved scientists. Following sustained criticism from the health and medical community about the industry's creation of the ATRF to further its objectives, the ATRF's scientific committee was provoked to publicly declare in 1988 that smoking was a causative agent in disease. This criticism led to growing ATRF boycotts by scientists and substandard applications, causing the industry to see the ATRF as being poor value-for-money and eventually abandoning it.

Conclusions: The raison d'etre for the ATRF's establishment was to allow the Australian industry to point to its continuing commitment to independent medical research, with the implied corollary that tobacco control measures were premature in the face of insufficient evidence about tobacco's harms. Sustained criticism of tobacco industry funded research schemes can undermine their credibility among the scientific community.

Full Text

The Full Text of this article is available as a PDF (223.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bryson A. M. Tobacco companies and research. Med J Aust. 1969 Jun 28;1(26):1387–1387. [PubMed] [Google Scholar]
  2. Chapman S., Carter S. M. "Avoid health warnings on all tobacco products for just as long as we can": a history of Australian tobacco industry efforts to avoid, delay and dilute health warnings on cigarettes. Tob Control. 2003 Dec;12 (Suppl 3):iii13–iii22. doi: 10.1136/tc.12.suppl_3.iii13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chapman S. Tobacco industry health research 'blood money': the British Health Promotion Research Trust. Community Health Stud. 1987;11(2):139–142. doi: 10.1111/j.1753-6405.1987.tb00144.x. [DOI] [PubMed] [Google Scholar]
  4. DOLL R., HILL A. B. Smoking and carcinoma of the lung; preliminary report. Br Med J. 1950 Sep 30;2(4682):739–748. doi: 10.1136/bmj.2.4682.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Shaw J. He who sups with the devil . . . Med J Aust. 1986 Jun 9;144(12):617–617. doi: 10.5694/j.1326-5377.1986.tb112338.x. [DOI] [PubMed] [Google Scholar]
  6. WYNDER E. L., GRAHAM E. A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc. 1950 May 27;143(4):329–336. doi: 10.1001/jama.1950.02910390001001. [DOI] [PubMed] [Google Scholar]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group

RESOURCES